The New Standard In Prenatal Care.
One blood draw for multiple insights. No male partner sample required for an accurate fetal risk.
Discover What Sets UNITY Complete Apart.
UNITY Complete Fetal Risk Screen is prenatal screening reimagined. It has earned a spot in AJHG’s Genomic Medicine Year in Review: 2023, recognized as a top 10 key advancement in applying genomics to clinical care.¹
The first and only test that uses cell-free DNA to provide precise fetal insights for both recessive and
With UNITY Fetal Risk Screen, the vast majority of patients will learn that there is a very low chance
Unlike other genetic testing options, UNITY Complete does not rely on the father for an
Know More. Know Early.
Identifying potential genetic conditions at the earliest stages is not just about preparation, it's about empowerment.
Request a Test KitUNITY Complete® accessible and affordable for all.
- We accept all insurances, including Medicaid
- We are in network with the majority of insurance plans
Early Intervention
UNITY Complete provides early detection of severe genetic conditions, early in a pregnancy. Knowing early allows access to timely interventions and treatments.
Informed Decisions
Knowledge is empowerment. You and your healthcare team can make informed and confident decisions about your care and management.
Peace Of Mind
99% of patients will learn there is a low chance that a baby will be born with certain genetic conditions2.
Preparation For Parenthood
Early insights enable you to prepare for the emotional, mental, and practical considerations for your new baby.
Take The Next Step With UNITY Complete.
Whether you are a provider looking to order your first UNITY Complete test, or an expectant parent wanting to know more, we are here to support your journey.
Providers
Patients
References
1. Teri A. Manolio, et al. Genomic medicine year in review: 2023, The American Journal of Human Genetics, Volume 110, Issue 12, Pages 1992-1995, https://doi.org/10.1016/j.ajhg.2023.11.001.
2. Wynn J, et al. Performance of single-gene noninvasive prenatal testing for autosomal recessive conditions in a general population setting. Prenat Diagn. 2023 Sep; 43(10):1344-1354. doi: 10.1002/pd.6427. Epub 2023 Sep 6. PMID: 37674263